ArticleFrontiers in immunology2023

ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma.

Mengzhou Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.